Stakes Are High For Companies Negotiating CIAs

Law360, New York (October 2, 2012, 1:27 PM EDT) -- Large pharmaceutical companies continue to resolve health care fraud investigations with epic settlements. As the dollars climb, the corporate integrity agreements (CIAs) typically filed in connection with these settlements are becoming increasingly onerous and stringent enforcement tools. GlaxoSmithKline PLC's July 2012 $3 billion settlement with the United States Attorney's Office for the District of Massachusetts has garnered attention not only due to its size, but also because of the unprecedented compliance obligations set forth in the corresponding CIA....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!